Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 363 of 1,261
  1. US 10934547

    Use of trinucleotide repeat RNAs to treat cancer

    Northwestern University · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  2. US 10934544

    Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  3. US 10934360

    Human monoclonal antibodies against EPHA4 and their use

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  4. US 10927161

    Methods for modulating an immune response

    Cue Biopharma, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  5. US 10927377

    Modulators of APOL1 expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  6. US 10928391

    CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  7. US 10927435

    Compositions for the treatment of rheumatoid arthritis and methods of using same

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  8. US 10927373

    Compositions and methods for inhibiting gene expression of Hif2alpha

    Arrowhead Pharmaceuticals, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  9. US 10927372

    Compositions and methods for modulating apolipoprotein C-III expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  10. US 10927362

    Processable single chain molecules and polypeptides made using same

    BIOVERATIV THERAPEUTICS INC. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  11. US 10927378

    Compound and method for treating myotonic dystrophy

    Sarepta Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  12. US 10927346

    Enhanced immune effector cells and use thereof

    Fate Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  13. US 10927193

    Gellan gum-based hydrogels, methods and uses thereof

    STEMMATTERS, BIOTECNOLOGIA E MEDICINA REGENERATIVA, S.A. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  14. US 10927165

    Antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  15. US 10927160

    Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

    The Regents of the University of California · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  16. US 10927158

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  17. US 10927136

    Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators

    Cyclerion Therapeutics, Inc. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  18. US 10927135

    Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  19. US 10927141

    Salts and crystal forms of GABAA positive allosteric modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  20. US 10927118

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  21. US 10927088

    Thymoquinone derivatives for treatment of cancer

    UNITED ARAB EMIRATES UNIVERSITY · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  22. US 10926073

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  23. US 10927124

    Compounds and compositions and uses thereof

    PGI Drug Discovery LLC · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted
  24. US 10927089

    Diaryl thioether piperazine compounds, preparation methods and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Feb 23, 2021 · Expires Feb 18, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.